Investor Alert

ADC Therapeutics S.A.



After Hours

 --Quotes are delayed by 20 min

Mar 31, 2023, 6:48 p.m.





+0.07 +3.59%


Volume 211

Quotes are delayed by 20 min


Previous close

$ 1.97

$ 1.95


-0.02 -1.02%

Day low

Day high




52 week low

52 week high




Annual Financials for ADC Therapeutics S.A.

Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Sales/Revenue 1.14M2.34M-33.92M209.91M
Cost of Goods Sold (COGS) incl. D&A --1.97M3.97M6.83M
COGS excluding D&A ---1.34M4.5M
Depreciation & Amortization Expense 513,0001.65M1.97M2.63M2.33M
Depreciation 488,0001.62M1.93M2.5M2.21M
Amortization of Intangibles 25,00030,00047,000129,000118,000
Gross Income --(1.97M)29.94M203.08M
20182019202020212022 5-year trend
SG&A Expense 126.34M118.44M216.49M291.3M326.12M
Research & Development 117.74M104.62M139.71M155.53M185.5M
Other SG&A 8.6M13.81M76.78M135.77M141.06M
Other Operating Expense -----
Unusual Expense 227,000-47.2M(34.89M)2.47M
EBIT after Unusual Expense (125.94M)-(265.66M)(226.46M)(125.51M)
Non Operating Income/Expense 213,000(255,000)(576,000)50,000(110,000)
Non-Operating Interest Income 2.86M2.25M832,00066,00017.97M
Equity in Affiliates (Pretax) -----
Interest Expense -156,0004.93M18.49M36.92M
Gross Interest Expense -156,0004.93M18.49M36.92M
Interest Capitalized -----
Pretax Income (122.87M)(115.9M)(270.33M)(244.83M)(144.58M)
Income Tax 224,000582,000327,000(21.48M)1.14M
Income Tax - Current Domestic 224,000582,000327,0004.57M1.85M
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic ---(26.05M)(708,000)
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates --24.37M(6.67M)(10.08M)
Other After Tax Income (Expense) -----
Consolidated Net Income (123.1M)(116.48M)(246.29M)(230.03M)(155.8M)
Minority Interest Expense -----
Net Income (123.1M)(116.48M)(246.29M)(230.03M)(155.8M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (123.1M)(116.48M)(246.29M)(230.03M)(155.8M)
Preferred Dividends -----
Net Income Available to Common (123.1M)(116.48M)(246.29M)(230.03M)(155.8M)
EPS (Basic) (33,019.00)(1.74)(3.77)(3.00)(1.99)
Basic Shares Outstanding 3,72866.87M65.41M76.75M78.15M
EPS (Diluted) (33,019.00)(1.74)(3.77)(3.00)(1.99)
Diluted Shares Outstanding 3,72866.87M65.41M76.75M78.15M
EBITDA (125.2M)(116.1M)(216.49M)(258.72M)(120.72M)
Link to MarketWatch's Slice.